Idera Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch IDRA and buy or sell other stocks, ETFs, and their options commission-free!About IDRA
Aceragen, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the research and development of medications for rare and orphan diseases.
CEOJohn Clayton Taylor
CEOJohn Clayton Taylor
Employees—
Employees—
HeadquartersResearch Triangle Park, North Carolina
HeadquartersResearch Triangle Park, North Carolina
Founded1989
Founded1989
Employees—
Employees—
IDRA Key Statistics
Market cap3.20M
Market cap3.20M
Price-Earnings ratio-0.07
Price-Earnings ratio-0.07
Dividend yield—
Dividend yield—
Average volume44.14K
Average volume44.14K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$16.00
52 Week high$16.00
52 Week low$0.3601
52 Week low$0.3601
Stock Snapshot
As of today, Idera Pharmaceuticals(IDRA) shares are valued at $1.60. The company's market cap stands at 3.2M, with a P/E ratio of -0.07.
On 2025-12-18, Idera Pharmaceuticals(IDRA) stock opened at —, reached a high of —, and a low of —.
The Idera Pharmaceuticals(IDRA)'s current trading volume is 0, compared to an average daily volume of 44.14K.
During the past year, Idera Pharmaceuticals(IDRA) stock moved between $0.36 at its lowest and $16.00 at its peak.
During the past year, Idera Pharmaceuticals(IDRA) stock moved between $0.36 at its lowest and $16.00 at its peak.